<DOC>
	<DOCNO>NCT01325194</DOCNO>
	<brief_summary>The purpose test whether early central nervous system ( CNS ) prophylaxis give begin therapy young high risk diffuse large B-cell lymphoma ( DLBCL ) patient feasible could reduce risk CNS relapse . Early CNS prophylaxis two course high dose methotrexate ( HD-MTX ) combination rituximab-cyclophosphamide-doxorubicin-vincristine-prednison ( R-CHOP ) follow four course R-CHOP14 etoposide ( E ) one course HD-Ara-C . In addition patient receive three course liposomal cytarabine intrathecally . The result compare recent Nordic CRY-04 study . Shifting CNS prophylaxis begin therapy offer potential overcome subclinical disease thus reduce risk early clinical CNS recurrence . As flow cytometry ( FCM ) improve sensitivity detect occult leptomeningeal disease cytology , FCM cerebrospinal fluid incorporate staging procedure .</brief_summary>
	<brief_title>CHemoImmunotherapy With Early Central Nervous System ( CNS ) Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Age â‰¥ 18 &lt; 65 year . Histologically confirm CD20+ diffuse large Bcell lymphoma ( DLBCL ) base WHO 2008 Lymphoma Classification Follicular lymphoma ( FLs ) grade 3b allowed Patients least stage II age adjust international prognostic score ( IPI score ) 2 3 : Stage III /IV elevate LDH Stage III/IV WHO performance status 2 3 Stage II elevate LDH WHO performance status 2 3 And/or patient More one extranodal site Testicular lymphoma , stage IIE high Paranasal sinus orbital lymphoma destruction bone Large cell infiltration bone marrow Severe cardiac disease : cardiac function grade 34 Impaired liver , renal organ function cause lymphoma , interfere treatment schedule Pregnancy/lactation Men woman reproductive potential agreeing use acceptable method birth control treatment six month completion treatment Patients severe medical problem expect short survival nonlymphoma reason Known HIV positivity Uncontrolled infectious disease , include meningeal infection Active cancer except basal cell carcinoma cervical carcinoma situ last five year Earlier treatment contain anthracyclins Psychiatric mental disorder make patient unable give inform consent and/or adhere protocol CNS disease diagnose MRI cerebrospinal fluid ( CSF ) cytology . Positive CSF flow cytometry diagnostic threshold level cytology allow Pleural peritoneal fluid drain safely Hypersensitivity active substance ingredient Patients participate clinical study , unless follow survival</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>DLBCL</keyword>
	<keyword>FL grade 3B</keyword>
	<keyword>high risk</keyword>
	<keyword>CNS prophylaxis</keyword>
	<keyword>chemoimmunotherapy</keyword>
</DOC>